Metagenomi Presents New Findings on CRISPR-Associated Transposases (CAST) that Allow for Targetable Genomic Integration of Large DNA Fragments

EMERYVILLE, Calif.--(BUSINESS WIRE)--Metagenomi, a gene editing company, today presented data on their novel CRISPR-associated transposases (CAST) system that allows for precise integration of large DNA fragments into genomes at the 24th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT), which is being held virtually. “Gene editing...

Click to view original post